Showing 1 - 5 results of 5 for search 'Alan M. Mendelsohn', query time: 0.29s
Refine Results
-
1
Clinical implications and predictive values of early PASI responses to tildrakizumab in patients with moderate-to-severe plaque psoriasis by Steven R. Feldman, Joseph F. Merola, David M. Pariser, Jingchuan Zhang, Yang Zhao, Alan M. Mendelsohn, Alice B. Gottlieb
Published 2022-04-01
Article -
2
Real-world treatment patterns and healthcare costs of biologics and apremilast among patients with moderate-to-severe plaque psoriasis by metabolic condition status by Steven R. Feldman, Jingchuan Zhang, Diane J. Martinez, Lorena Lopez-Gonzalez, Elizabeth Hoit Marchlewicz, George Shrady, Alan M. Mendelsohn, Yang Zhao
Published 2021-02-01
Article -
3
Sustained and continuously improved efficacy of tildrakizumab in patients with moderate-to-severe plaque psoriasis by Boni Elewski, Alan Menter, Jeffrey Crowley, Stephen Tyring, Yang Zhao, Simon Lowry, Stephen Rozzo, Alan M. Mendelsohn, Jeffrey Parno, Kenneth Gordon
Published 2020-11-01
Article -
4
-
5
Topical Isotretinoin (TMB-001) Treatment for 12 Weeks Did Not Result in Clinically Relevant Laboratory Abnormalities in Participants with Congenital Ichthyosis in the Phase 2b CONT... by Kalyani Marathe, Joyce M. C. Teng, Scott Guenthner, Christopher G. Bunick, Steven Kempers, Kimmie Eads, Leslie Castelo-Soccio, Alan M. Mendelsohn, Jessica Raiz, Dédée F. Murrell
Published 2023-05-01
Article